Applicant, as named in the Orange Book

Chartwell Rx

Products with listed protection

DrugEarliest generic entry

None.

Recent events

  • Monodox · Generic approved · ANDA 219978, Aiping Pharm IncApproved 1 Oct 2025Detected 25 Oct 2026
  • Tazorac · Generic approved · ANDA 214560, Solaris Pharma CorpApproved 24 Nov 2025Detected 25 Oct 2026
  • Acticlate Cap · Generic approved · ANDA 211137, Macleods PharmsApproved 9 Dec 2025Detected 25 Oct 2026
Products without listed protection (6)
DrugEarliest generic entry
Acticlate
NDA 205931 · 2 strengths
doxycycline hyclate
open now
no listed protection
Avage
NDA 021184
tazarotene
open now
no listed protection
Monodox
NDA 050641 · 4 strengths
doxycycline
open now
no listed protection
Tazorac
NDA 020600 · 2 strengths
tazarotene
open now
no listed protection
Tazorac
NDA 021184 · 2 strengths
tazarotene
open now
no listed protection
Veltin
NDA 050803
clindamycin phosphate; tretinoin
open now
no listed protection